Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-14413-w.pdf
Reference45 articles.
1. Schroder, F., Crawford, E. D., Axcrona, K., Payne, H. & Keane, T. E. Androgen deprivation therapy: past, present and future. BJU Int. 109, 1–12 (2012).
2. Heidenreich, A. et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur. Urol. 65, 467–479 (2014).
3. Lepor, H. & Shore, N. D. LHRH Agonists for the Treatment of Prostate Cancer: 2012. Rev. Urol. 14, 1–12 (2012).
4. Baciarello, G. & Sternberg, C. N. Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide. Crit. Rev. Oncol. Hematol. 106, 14–24 (2016).
5. Rick, F. G. & Schally, A. V. Bench-to-bedside development of agonists and antagonists of luteinizing hormone-releasing hormone for treatment of advanced prostate cancer. Urol. Oncol. Semin. Orig. Investig. 33, 270–274 (2015).
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, Synthesis, and In Vitro and In Vivo Bioactivity Studies of Hydrazide–Hydrazones of 2,4-Dihydroxybenzoic Acid;International Journal of Molecular Sciences;2023-12-14
2. A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway;iScience;2022-05
3. Zebrafish xenotransplantation: A versatile platform for cancer and stem cell translational research;Cellular and Molecular Approaches in Fish Biology;2022
4. Androgen Deprivation Therapy, Hypogonadism and Cardiovascular Toxicity in Men with Advanced Prostate Cancer;Current Oncology;2021-08-28
5. Improving the sexual activity and reproduction of female zebrafish with high testosterone levels;Scientific Reports;2021-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3